1 | 31 | 54 | M | Epistaxis | Proptosis, epiphora | Clinical and imaging progression | NA | D | T4N1M1 | 3 | NA |
2 | 72 | 73 | F | Anosmia, nasal obstruction | Asymptomatic | Imaging progression | Grade 2 | D | T2N1M1 | 4 | Positive concordant |
3 | 55 | 65 | M | Nasal obstruction | Dysphagia | Clinical and imaging progression | Grade 2 | D | T2N1M1 | 2–3 | Positive concordant |
4 | 39 | 39 | F | Anosmia, nasal obstruction, epistaxis | Severe scalp pain | Clinical and imaging progression | Grade 2 | D | T4N1M1 | 3 | Positive concordant |
5 | 48 | 48 | M | Anosmia, nasal obstruction | Partial vision loss | Clinical and imaging progression | Grade 2 | D | T4N0M1 | 3 | Positive concordant |
6 | 40 | 48 | M | Epistaxis, nasal obstruction | Chest pain, coughing | Clinical and imaging progression | NA | D | T4N1M1 | 4 | Positive concordant |
7 | 67 | 77 | F | Swelling, anosmia, nasal obstruction | Asymptomatic | Imaging progression | NA | D | T4N1M1 | 4 | Positive but less than on Ga-TATE |